Absci (ABSI) Debt Ratio (2020 - 2025)
Absci's (ABSI) quarterly Debt Ratio came in at 0.05 in Q3 2025, up 470.97% year-on-year from 0.01 in Q3 2024, and down 14.96% quarter-over-quarter from 0.06 in Q2 2025.
Absci (ABSI) Debt Ratio (2020 - 2025) Analysis & Trends
Absci has disclosed Debt Ratio across 6 years of filings, most recently posting 0.05 for Q3 2025.
- Debt Ratio for Q3 2025 came in at 0.05, up 470.97% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.05 (up 470.97% YoY), and the FY2024 annual result was 0.07, down 18.16% from the prior year.
- Debt Ratio came in at 0.05 for Q3 2025 at Absci, down from 0.06 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.08 in Q4 2023 to a low of 0.0 in Q1 2022.
- The 5-year median for Debt Ratio is 0.02 (2022), against an average of 0.03.
- Across the five-year window, Debt Ratio slumped 95.11% in 2021 and surged 1710.2% in 2023, its largest moves.
- Absci's Debt Ratio stood at 0.0 in 2021, then surged by 843.08% to 0.02 in 2022, then jumped by 222.14% to 0.08 in 2023, then dropped by 18.16% to 0.07 in 2024, then declined by 20.23% to 0.05 in 2025.
- The last three Debt Ratio figures came in at 0.05 (Q3 2025), 0.06 (Q2 2025), and 0.06 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.18 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.05 |
| Jun 30, 2025 | 0.06 |
| Mar 31, 2025 | 0.06 |
| Dec 31, 2024 | 0.07 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.08 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.01 |
| Dec 31, 2020 | 0.05 |